Breakthrough in Specimen Banking Supports High-tech Research
News Sep 29, 2012
A well-administered biobank is critical for conducting high-quality sophisticated biological research, and NovoBioBank provides all necessary tools. This fully customizable intuitive software solution, based on user-designed specs, supports effortless, scalable collaboration between multiple sites. NovoBioBank is a robust, flexible module that enables collection of pertinent specimen data, extensive search parameters and on-the-spot information – including order status, shipping, billing and maintenance reports.
NovoBioBank supports the capture, standardization and organization of wide-ranging relevant data – both patient/donor and biospecimen oriented – providing secure access to well-annotated biospecimens, while maintaining confirmed chain of custody. Data is managed and tracked through all phases of the complete biospecimen life-cycle – from informed consent, through annotation, collection, processing, QA, inventory/archival control, distribution fulfillment, and finally, to disposal. Full search capacity of operator-defined annotation and query criteria cover all data parameters from patient/donor demographics through to specimen molecular analysis – and everything in between.
Tim Marshall, NovoPath’s Vice President of Strategic Account Development, stated, “Today, biospecimens are being tapped to support research geared toward understanding the mechanisms of disease, identifying novel drug targets, developing clinically relevant biomarkers and an expansive range of cutting-edge research. NovoBioBank now stands ready to help researchers harness the true power and value in their biobank, fueling contemporary investigation – from basic research to clinical trials – through the better management of well-characterized biospecimens.”
New Biomarkers Predict Outcome of Cancer ImmunotherapyNews
Researchers at the University of Zurich have identified biomarkers in the blood that make it possible to predict whether cancer patients will respond positively to immunotherapy. Patients for whom therapy does not work can thus be treated using different methods at an earlier stage.READ MORE
Cellular Judge Rules on Fate of mRNAs under Sugar StressNews
A newly discovered protein, Puf5P, has been shown to arbitrate on which mRNAs are stored and which are destroyed.READ MORE
Peli BioThermal Hires Dominic Hyde as New VP of Crēdo™ on DemandNews
Radical expansion of global rental program includes adding staff, locations and doubling their container inventory.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018